MicroRNAs have been reported to play an important role in tumor development and progression by targeting oncogenes and tumor suppressors. miR-23a has been described as significantly upregulated in multiple cancers and involved in tumorigenesis. The aim of this study was to evaluate the potential roles of miR-23a in pancreatic ductal adenocarcinoma (PDAC). We found that miR-23a level was significantly increased in tissues of PDAC compared with that in the control by real-time PCR. FOXP2 expression was downregulated and inversely correlated with miR-23a. miR-23a directly targeted the 3’-untranslated region of FOXP2 mRNA and repressed its expression. Mechanistically, enhancement of miR-23a by transfection with mimics in Aspc-1 cells significantly promoted cell proliferation and invasion, while miR-23a inhibitors transfection in SW1990 cells induced an inhibitory effect. Moreover, restoration of FOXP2 impaired the pro-proliferation and proinvasion effects of miR-23a, indicating FOXP2 is a direct mediator of miR-23a functions. In conclusion, our findings suggest a novel miR-23a/FOXP2 link contributing to PDAC development and invasion. It may be a potential diagnostic and therapeutic target for PDAC.
WinterJ, JungS, KellerS, . Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol2009;11:228–34.doi:10.1038/ncb0309-228
5.
PetrovicN, ErgünS, IsenovicER. Levels of microrna heterogeneity in cancer biology. Mol Diagn Ther2017:511–23.doi:10.1007/s40291-017-0285-9
6.
FaziF, BlandinoG. MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment. Microrna2013;2:81.doi:10.2174/2211536611302020001
7.
WangH. Predicting cancer-related MiRNAs using expression profiles in tumor tissue. Curr Pharm Biotechnol2014;15:438–44.doi:10.2174/1389201015666140519121255
8.
BarbarottoE, SchmittgenTD, CalinGA. MicroRNAs and cancer: profile, profile, profile. Int J Cancer2008;122:969–77.doi:10.1002/ijc.23343
9.
KasinskiAL, SlackFJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer2011;11:849–64.doi:10.1038/nrc3166
10.
QuWQ, LiuL, YuZ. Clinical value of microRNA-23a upregulation in non-small cell lung cancer. Int J Clin Exp Med2015;8:13598–603.
11.
ZhangXW, LiuN, ChenS, . Upregulation of microRNA-23a regulates proliferation and apoptosis by targeting APAF-1 in laryngeal carcinoma. Oncol Lett2015;10:410–6.doi:10.3892/ol.2015.3238
12.
ZhouQ, GallagherR, Ufret-VincentyR, . Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters. Proc Natl Acad Sci U S A2011;108:8287–92.doi:10.1073/pnas.1105254108
13.
FramptonAE, CastellanoL, ColomboT, . Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression. Lancet2015;385(Suppl 1):S37.doi:10.1016/S0140-6736(15)60352-X
14.
MyattSS, LamEW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer2007;7:847–59.doi:10.1038/nrc2223
15.
VicarioCM. FOXP2 gene and language development: the molecular substrate of the gestural-origin theory of speech?Front Behav Neurosci2013;7:99.doi:10.3389/fnbeh.2013.00099
16.
KyriazisAP, McCombsWB, SandbergAA, . Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse. Cancer Res1983;43:4393–401.
17.
LiuC, LiB, ChengY, . MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3. Int J Biol Sci2011;7:347–63.doi:10.7150/ijbs.7.347
18.
DalmayT, EdwardsDR. MicroRNAs and the hallmarks of cancer. Oncogene2006;25:6170–5.doi:10.1038/sj.onc.1209911
19.
LiJ, TanS, KoogerR, . MicroRNAs as novel biological targets for detection and regulation. Chem Soc Rev2014;43:506–17.doi:10.1039/C3CS60312A
20.
PiepoliA, TavanoF, CopettiM, . Mirna expression profiles identify drivers in colorectal and pancreatic cancers. PLoS One2012;7:e33663.doi:10.1371/journal.pone.0033663
21.
HumeauM, Vignolle-VidoniA, SicardF, . Salivary microRNA in pancreatic cancer patients. PLoS One2015;10:e0130996.doi:10.1371/journal.pone.0130996
22.
FramptonAE, CastellanoL, ColomboT, . MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. Gastroenterology2014;146:268–77.doi:10.1053/j.gastro.2013.10.010
23.
ListingH, MardinWA, WohlfrommS, . MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer. Br J Cancer2015;112:131–9.doi:10.1038/bjc.2014.587
24.
MaF, LiW, LiuC, . MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling. Oncotarget2017;8:69538–50.doi:10.18632/oncotarget.18422
25.
LiX, LiX, LiaoD, . Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with microsatellite instability to 5-fluorouracil by directly targeting ABCF1. Curr Protein Pept Sci2015;16:301–9.
26.
HeY, MengC, ShaoZ, . MiR-23a functions as a tumor suppressor in osteosarcoma. Cell Physiol Biochem2014;34:1485–96.doi:10.1159/000366353
27.
Aghaee-BakhtiariSH, ArefianE, NaderiM, . MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches. Tumour Biol2015;36:4203–12.doi:10.1007/s13277-015-3057-3
28.
LiuN, SunYY, ZhangXW, . Oncogenic miR-23a in pancreatic ductal adenocarcinogenesis via inhibiting APAF1. Dig Dis Sci2015;60:2000–8.doi:10.1007/s10620-015-3588-x
29.
QuJQ, YiHM, YeX, . MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway. Oncotarget2015;6:28341–56.doi:10.18632/oncotarget.5117
30.
CaoM, LiY, LuH, . MiR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells. J Cancer Res Clin Oncol2014;140:1661–70.doi:10.1007/s00432-014-1725-0
31.
ZhengH, LiW, WangY, . miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer. Carcinogenesis2014;35:173–83.doi:10.1093/carcin/bgt274
32.
ChiuYC, LiMY, LiuYH, . Foxp2 regulates neuronal differentiation and neuronal subtype specification. Dev Neurobiol2014;74:723–38.doi:10.1002/dneu.22166
33.
SpaethJM, HunterCS, BonatakisL, . The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice. Diabetologia2015;58:1836–44.doi:10.1007/s00125-015-3635-3
34.
YanX, ZhouH, ZhangT, . Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion. Tumour Biol2015;36:9611–9.doi:10.1007/s13277-015-3701-y
35.
GascoyneDM, SpearmanH, LyneL, . The Forkhead transcription factor FOXP2 is required for regulation of p21WAF1/CIP1 in 143B osteosarcoma cell growth arrest. PLoS One2015;10:e0128513.doi:10.1371/journal.pone.0128513
36.
SethiS, AliS, PhilipPA, . Clinical advances in molecular biomarkers for cancer diagnosis and therapy. Int J Mol Sci2013;14:14771–84.doi:10.3390/ijms140714771
37.
SeguraMF, GreenwaldHS, HannifordD, . MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis2012;33:1823–32.doi:10.1093/carcin/bgs205
38.
BouchieA. First microRNA mimic enters clinic. Nat Biotechnol2013;31:577.doi:10.1038/nbt0713-577
39.
XiaoF, BaiY, ChenZ, . Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. Eur J Cancer2014;50:1541–54.doi:10.1016/j.ejca.2014.01.024
40.
HayesJ, PeruzziPP, LawlerS. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med2014;20:460–9.doi:10.1016/j.molmed.2014.06.005
